Literature DB >> 7512424

Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants: a potential role in osteolysis.

N al Saffar1, P A Revell.   

Abstract

IL-1 producing cells at the bone-implant interface obtained during revision of loosened total joint replacements were demonstrated by immunohistochemistry on tissue sections. Other markers for the characterization of macrophages, B cells, T cell subpopulations, IL-2 receptor and HLA-DR antigens were also used. The 10 cases examined showed excessive metallosis within the cytoplasm of the macrophages and extracellular matrix. IL-1 beta containing cells were found in seven cases, four of which showed positive staining on more than 80% of the macrophages. A relatively similar proportion of T cells was seen in all the cases. T helper (CD4 positive) cells were always present in excess of T suppressor (CD8 positive) subtype. T cells showed no expression of detectable membrane IL-2 receptor. No B cells were found in these cases. Macrophages showed very strong immunostaining for HLA-DR. These findings indicate the possible induction of IL-1 production by activated macrophages in the interface in response to the presence of metallic wear debris. In view of the well known effect of IL-1 as a potent mediator of bone lysis, the results suggest a major role of the metal debris-containing macrophages in the process of osteolysis and subsequent implant loosening.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512424     DOI: 10.1093/rheumatology/33.4.309

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  26 in total

1.  Modulation of the phenotypic and functional properties of phagocytic macrophages by wear particles from orthopaedic implants.

Authors:  N Al-Saffar; P A Revell; A Kobayashi
Journal:  J Mater Sci Mater Med       Date:  1997-11       Impact factor: 3.896

Review 2.  The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses.

Authors:  Peter A Revell
Journal:  J R Soc Interface       Date:  2008-11-06       Impact factor: 4.118

3.  Neovascularisation and the induction of cell adhesion molecules in response to degradation products from orthopaedic implants.

Authors:  N al-Saffar; J T Mah; Y Kadoya; P A Revell
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103

4.  Metallosis and Metal-Induced Synovitis Following Total Knee Arthroplasty: Review of Radiographic and CT Findings.

Authors:  Jason W Romesburg; Paul L Wasserman; Candace H Schoppe
Journal:  J Radiol Case Rep       Date:  2010-09-01

5.  Role of polyethylene particles in peri-prosthetic osteolysis: A review.

Authors:  Gerald J Atkins; David R Haynes; Donald W Howie; David M Findlay
Journal:  World J Orthop       Date:  2011-10-18

Review 6.  Contributions of human tissue analysis to understanding the mechanisms of loosening and osteolysis in total hip replacement.

Authors:  Jiri Gallo; Jana Vaculova; Stuart B Goodman; Yrjö T Konttinen; Jacob P Thyssen
Journal:  Acta Biomater       Date:  2014-02-10       Impact factor: 8.947

7.  Evidence for active antigen presentation by monocyte/macrophages in response to stimulation with particles: the expression of NFκB transcription factors and costimulatory molecules.

Authors:  Huwaidha Altaf; Peter A Revell
Journal:  Inflammopharmacology       Date:  2013-05-14       Impact factor: 4.473

8.  Adhesion of microvascular endothelial cells to metallic implant surfaces.

Authors:  R A Smith; M W Mosesson; A U Daniels; T K Gartner
Journal:  J Mater Sci Mater Med       Date:  2000-05       Impact factor: 3.896

9.  Direct activation of mast cells by prosthetic biomaterial particles.

Authors:  N Al-Saffar; H Iwaki; P A Revell
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

10.  Interleukin 15 production by macrophages in the implant interface membrane of aseptically loosened joint replacements.

Authors:  P A Revell; S E Jellie
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.